Market Overview

Cantor Fitzgerald Reiterates Hold, $29 PT on Centene Amid Challenges

Share:
Related CNC
Molina Healthcare's Issues Aren't Permanent, JPMorgan Says Amid Upgrade
Humana, Anthem Benefit From 'Attractive' Managed Care Sector, Jefferies Says
UnitedHealth's Q4 beat buoys peers (Seeking Alpha)

Cantor Fitzgerald reiterates its Hold rating and $29 price target on Centene (NYSE: CNC) on lack of visibility amid challenges emanating from the company's recent earnings shortfall.

Cantor Fitzgerald comments, "Centene used today's Investor Day to add detail regarding Monday's announcement of a big earnings shortfall and to lay out its action plan. Significant steps are being taking at each of the company's affected businesses, and it is reviewing Celtic, but while it appears confident that these problems will be resolved, the path is neither simple nor obviously developed according to a specific timeline. We like the detailed analysis of the problem and the plan, but prefer to at least wait for the 2Q:12 earnings call (and an update) before stepping up to the stock."

CNC closed at $28.20 on Thursday.

Latest Ratings for CNC

DateFirmActionFromTo
Jan 2018Goldman SachsInitiates Coverage OnBuy
Nov 2017Credit SuisseInitiates Coverage OnNeutral
Oct 2017OppenheimerMaintainsOutperform

View More Analyst Ratings for CNC
View the Latest Analyst Ratings

Posted-In: Cantor FitzgeraldAnalyst Color Price Target Reiteration Pre-Market Outlook Analyst Ratings

 

Related Articles (CNC)

View Comments and Join the Discussion!